CDC Names Surgeon General as Deputy Director, Despite "Dangerous" Views on Vaccines.
The Centers for Disease Control and Prevention (CDC) has appointed Louisiana Surgeon General Ralph Abraham as its new principal deputy director under the leadership of Health Secretary Robert F. Kennedy Jr., a choice that experts describe as "dangerous" but not entirely alarming. The decision has sparked concern among public health advocates, who are worried about the implications for vaccine policies and research at the CDC.
Abraham has been vocal in his opposition to vaccines, stating in February that he does not recommend COVID-19 vaccines because he prefers natural immunity. He has also expressed skepticism about the safety and effectiveness of vaccines, which is a departure from the mainstream scientific consensus on the matter.
In addition to his anti-vaccine views, Abraham's leadership style has been criticized by public health experts, who have pointed out that during his time as head of the Louisiana Department of Health, he delayed informing residents about a deadly pertussis outbreak for several months. He also ordered the department to stop promoting mass vaccinations and barred staff from running seasonal vaccine campaigns.
Despite these concerns, Abraham's appointment at the CDC has been seen by some experts as a more palatable option compared to other candidates considered for the position. Physician Jeremy Faust pointed out that while Abraham's views on vaccines are "probably pretty terrible," he at least has relevant experience in public health policy.
However, the appointment is part of a broader effort by Kennedy Jr. to reshape the CDC and promote unproven ideas about COVID-19 treatment, including the use of anti-malarial drugs like hydroxychloroquine and ivermectin. The agency's website was recently rewritten to falsely link vaccines to autism, which has been widely discredited by scientific experts.
The appointment of Abraham as deputy director at the CDC is a significant development in Kennedy Jr.'s efforts to push his anti-vaccine agenda within the agency. It remains to be seen how he will implement these views and policies during his tenure, but public health advocates are likely to closely monitor any developments that may impact vaccine policy or research at the CDC.
The Centers for Disease Control and Prevention (CDC) has appointed Louisiana Surgeon General Ralph Abraham as its new principal deputy director under the leadership of Health Secretary Robert F. Kennedy Jr., a choice that experts describe as "dangerous" but not entirely alarming. The decision has sparked concern among public health advocates, who are worried about the implications for vaccine policies and research at the CDC.
Abraham has been vocal in his opposition to vaccines, stating in February that he does not recommend COVID-19 vaccines because he prefers natural immunity. He has also expressed skepticism about the safety and effectiveness of vaccines, which is a departure from the mainstream scientific consensus on the matter.
In addition to his anti-vaccine views, Abraham's leadership style has been criticized by public health experts, who have pointed out that during his time as head of the Louisiana Department of Health, he delayed informing residents about a deadly pertussis outbreak for several months. He also ordered the department to stop promoting mass vaccinations and barred staff from running seasonal vaccine campaigns.
Despite these concerns, Abraham's appointment at the CDC has been seen by some experts as a more palatable option compared to other candidates considered for the position. Physician Jeremy Faust pointed out that while Abraham's views on vaccines are "probably pretty terrible," he at least has relevant experience in public health policy.
However, the appointment is part of a broader effort by Kennedy Jr. to reshape the CDC and promote unproven ideas about COVID-19 treatment, including the use of anti-malarial drugs like hydroxychloroquine and ivermectin. The agency's website was recently rewritten to falsely link vaccines to autism, which has been widely discredited by scientific experts.
The appointment of Abraham as deputy director at the CDC is a significant development in Kennedy Jr.'s efforts to push his anti-vaccine agenda within the agency. It remains to be seen how he will implement these views and policies during his tenure, but public health advocates are likely to closely monitor any developments that may impact vaccine policy or research at the CDC.